← Back to Search

Monoclonal Antibodies

AGEN2034 for Cervical Cancer

Phase 1 & 2
Waitlist Available
Research Sponsored by Agenus Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of the trial, up to 4 years
Awards & highlights

Study Summary

This trial is testing a new treatment for cervical cancer in two parts. The first part is to see what dose is safe for people with cancer that has spread or is hard to treat. The second part is to see if the new treatment can help people with cancer that has come back or spread after other treatments.

Eligible Conditions
  • Cancer
  • Cervical Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of the trial, up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of the trial, up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Objective Response Rate (ORR), as determined by IERC, in the analysis population
Secondary outcome measures
Area under the drug concentration-time curve from time zero to time t (AUC(0-t)), area under the drug concentration-time curve from time zero to infinity (AUC(0-∞))
Area under the drug concentration-time curve within time span t1 to t2 at steady-state (AUC(τ1-τ2)-ss)
Disease Control Rate (DCR)
+15 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: MonotherapyExperimental Treatment1 Intervention
Dose of 3 mg/kg IV every 2 weeks for up to 24 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AGEN2034
2017
Completed Phase 2
~220

Find a Location

Who is running the clinical trial?

Agenus Inc.Lead Sponsor
51 Previous Clinical Trials
4,600 Total Patients Enrolled
Medical DirectorStudy DirectorAgenus Inc.
2,777 Previous Clinical Trials
8,063,677 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of AGEN2034 in Advanced Tumors and Cervical Cancer
2017. "Study of AGEN2034 in Advanced Tumors and Cervical Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03104699.
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top